Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of CHF 178.12 billion. The enterprise value is 199.52 billion.
Market Cap | 178.12B |
Enterprise Value | 199.52B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | Mar 11, 2025 |
Share Statistics
Novartis AG has 1.96 billion shares outstanding. The number of shares has decreased by -2.90% in one year.
Current Share Class | 1.96B |
Shares Outstanding | 1.96B |
Shares Change (YoY) | -2.90% |
Shares Change (QoQ) | -1.25% |
Owned by Insiders (%) | 0.11% |
Owned by Institutions (%) | 38.34% |
Float | 1.87B |
Valuation Ratios
The trailing PE ratio is 16.13 and the forward PE ratio is 12.79. Novartis AG's PEG ratio is 1.61.
PE Ratio | 16.13 |
Forward PE | 12.79 |
PS Ratio | 3.79 |
PB Ratio | 5.24 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.11, with an EV/FCF ratio of 12.82.
EV / Earnings | 17.55 |
EV / Sales | 4.24 |
EV / EBITDA | 10.11 |
EV / EBIT | 12.72 |
EV / FCF | 12.82 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.
Current Ratio | 0.79 |
Quick Ratio | 0.50 |
Debt / Equity | 0.81 |
Debt / EBITDA | 1.40 |
Debt / FCF | 1.78 |
Interest Coverage | 16.83 |
Financial Efficiency
Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.
Return on Equity (ROE) | 32.89% |
Return on Assets (ROA) | 11.42% |
Return on Invested Capital (ROIC) | 16.23% |
Return on Capital Employed (ROCE) | 25.98% |
Revenue Per Employee | 619,975 |
Profits Per Employee | 149,793 |
Employee Count | 75,883 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.24 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.69% in the last 52 weeks. The beta is 0.53, so Novartis AG's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | -0.69% |
50-Day Moving Average | 94.60 |
200-Day Moving Average | 95.18 |
Relative Strength Index (RSI) | 46.74 |
Average Volume (20 Days) | 3,986,994 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of CHF 47.05 billion and earned 11.37 billion in profits. Earnings per share was 5.64.
Revenue | 47.05B |
Gross Profit | 35.60B |
Operating Income | 15.69B |
Pretax Income | 13.19B |
Net Income | 11.37B |
EBITDA | 19.52B |
EBIT | 15.69B |
Earnings Per Share (EPS) | 5.64 |
Balance Sheet
The company has 6.31 billion in cash and 27.64 billion in debt, giving a net cash position of -21.33 billion or -10.89 per share.
Cash & Cash Equivalents | 6.31B |
Total Debt | 27.64B |
Net Cash | -21.33B |
Net Cash Per Share | -10.89 |
Equity (Book Value) | 33.99B |
Book Value Per Share | 17.31 |
Working Capital | -5.76B |
Cash Flow
In the last 12 months, operating cash flow was 16.79 billion and capital expenditures -1.23 billion, giving a free cash flow of 15.56 billion.
Operating Cash Flow | 16.79B |
Capital Expenditures | -1.23B |
Free Cash Flow | 15.56B |
FCF Per Share | 7.94 |
Margins
Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.
Gross Margin | 75.68% |
Operating Margin | 33.35% |
Pretax Margin | 28.03% |
Profit Margin | 24.16% |
EBITDA Margin | 41.50% |
EBIT Margin | 33.35% |
FCF Margin | 33.08% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.85%.
Dividend Per Share | 3.50 |
Dividend Yield | 3.85% |
Dividend Growth (YoY) | -56.79% |
Years of Dividend Growth | n/a |
Payout Ratio | 60.27% |
Buyback Yield | 2.90% |
Shareholder Yield | 6.75% |
Earnings Yield | 6.38% |
FCF Yield | 8.74% |
Stock Splits
The last stock split was on May 7, 2001. It was a forward split with a ratio of 40.
Last Split Date | May 7, 2001 |
Split Type | Forward |
Split Ratio | 40 |
Scores
Novartis AG has an Altman Z-Score of 3.71.
Altman Z-Score | 3.71 |
Piotroski F-Score | n/a |